Female Reproductive Endocrinology

Similar documents
Overview of Reproductive Endocrinology

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

Polycystic Ovary Syndrome

Abnormal Uterine Bleeding Case Studies

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

Polycystic Ovary Syndrome


Dr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO

Reproductive Health and Pituitary Disease

Secondary amenorrhoea Dr.ASMAA AL SANJARY

Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology

Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

13 th Annual Women s Health Day PCOS. Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...

Polycystic Ovary Syndrome

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS

New PCOS guidelines: What s relevant to general practice

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

Fertility assessment and assisted conception

Dr Mary Birdsall. Fertility Associates Auckland

Polycystic Ovary Syndrome: Cardiovascular Disease risk

What is polycystic ovary syndrome? What are polycystic ovaries? What are the symptoms of PCOS?

INFERTILITY CAUSES. Basic evaluation of the female

PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary

Amenorrhoea: polycystic ovary syndrome

Polycystic Ovarian Syndrome (PCOS) LOGO

06-Mar-17. Premature menopause. Menopause. Premature menopause. Menstrual cycle oestradiol. Premature menopause. Prevalence ~1% Higher incidence:

Polycystic Ovary Syndrome (PCOS):

Polycystic Ovary Syndrome

Mechanism of hyperprolactinemia

PCOS. Kirtly Parker Jones MD

PCOS guidelines: What s relevant to general practice

REPRODUCTIVE ENDOCRINOLOGY

Gonadotrophin treatment in patients with Polycystic Ovary Syndrome

Topics. Periods Menopause & HRT Contraception Vulva problems

Polycystic ovary syndrome (PCOS)

Puberty and Fertility. Normal Female Puberty PUBERTY! What about girls with Galactosemia? E Puberty and Fertility Badik Spencer 1

F REQUENTLY A SKED Q UESTIONS

Neuroendocrine Disorders in Women

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

Polycystic Ovary Disease: A Common Endocrine Disorder in Women

Polycystic Ovary Syndrome (PCOS)

Polycystic ovary syndrome

PCOS and Obesity DUB is better treated by OCPs

JMSCR Vol 05 Issue 05 Page May 2017

Information for you. What is polycystic ovary syndrome? Polycystic ovary syndrome: what it means for your long-term health

Infertility History Form

PCOS and Your Fertility. Jim Toner, MD, PhD Atlanta Center for Reproductive Medicine

Reproductive Testing: Less is More G. Wright Bates, Jr., M.D. Professor and Director Reproductive Endocrinology and Infertility Objectives

Ovaries: In Sickness and Health. Mr N Pisal Consultant Gynaecologist The Portland Hospital

POLYCYSTIC OVARIAN SYNDROME WHERE WE ARE AT IN 2018

Subfertility B Y A L I S O N, B E N A N D J O H N

3. Metformin therapy for PCOS

Polycystic Ovary Syndrome (PCOS)

Approach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD

POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015

GONADAL FUNCTION: An Overview

Infertility DR. RAHUL BEVARA

16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA

From the editors desk

Difference Between PCOS and Endometriosis

Clinical Problems in the Diagnosis and Treatment of PCOS During Adolescence

Polycystic Ovary Syndrome

Abstract. Introduction. RBMOnline - Vol 10. No Reproductive BioMedicine Online; on web 15 November 2004

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations

Objectives 06/21/18 STILL A PLACE FOR PILLS DON T IVF EVERYTHING. Clomiphene citrate and Letrozole. Infertility Case Studies. Unexplained Infertility

Primary Care Gynaecology Guidelines: HEAVY REGULAR MENSTRUAL BLEEDING

ASK PCOS. Evidence-based information for women with Polycystic ovary syndrome

GLMS CME- Cell Group 5 10 April Greenlane Medical Specialists Pui-Ling Chan Endocrinologist

Prof. Dr. Michael Zitzmann Internal Medicine Endocrinology, Diabetology, Andrology University of Muenster, Germany

PUBERTY. Preetha Krishnamoorthy. Division of Pediatric Endocrinology

Neil Goodman, MD, FACE

Managing polycystic ovary syndrome in primary care

Fertility in the 21 st Century Dr Leigh Searle

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Management of Female infertility Tim Chang

Polycystic Ovary Syndrome

Infertility: A Generalist s Perspective

Low AMH and natural conception. Dr. Phil Boyle Galway, Ireland IIRRM Annual Meeting, 7 th August 2013

POTION OR POISON? MEDICAL TREATMENT ALTERNATIVES TO THE PILL. Lester Ruppersberger, D.O., FACOOG,CNFPI NFP only Gynecologist

The assessment and investigation of the infertile couple

Pituitary for the General Practitioner. Marilyn Lee Consultant physician and endocrinologist

FERTILITY & TCM. On line course provided by. Taught by Clara Cohen

Management of polycystic ovarian syndrome

Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital

PCOS The intersection of sex hormones & metabolism. Educational Objectives. Presenter Disclosure Information. Polycystic Ovary Syndrome

ROLE OF METFORMIN IN POLYCYSTIC OVARIAN SYNDROME

2.0 Synopsis. Lupron Depot M Clinical Study Report R&D/09/093. (For National Authority Use Only) to Part of Dossier: Name of Study Drug:

Disclosure. Outline. Obesity: Endocrine Issues as the Cause and as the Effect 4/5/2016

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks

Endocrine control of female reproductive function

THYROID PROFILE IN POLYCYSTIC OVARIAN SYNDROME Sudhanshu Sekhara Nanda 1, Subhalaxmi Dash 2, Ashok Behera 3, Bharati Mishra 4

REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W

By Jennifer F. Teskey, MD; Heather J. Dean, MD, FRCPC; and Elizabeth AC Sellers, MSc, MD, FRCPC. amenorrhea. Following menarche 3. How to treat PCOS.

Infertility Investigations. Patient Information

Transcription:

Female Reproductive Endocrinology Dr. Channa Jayasena PhD MRCP FRCPath Clinical Senior Lecturer & Consultant Endocrinologist Department of Gynaecology, Hammersmith Hospital

Anovulation is a common cause of infertility Disorders of ovulation account for about 25% of causes of infertility Most are due to abnormal endocrine environment Most are treatable

Presentation of anovulation Amenorrhoea (primary or secondary) Oligomenorrhoea (cycle >42 days) Irregular menses (e.g. cycles varying between 2 and 6 weeks in duration)

Female reproductive axis

Causes of anovulation PCOS (60%) Functional hypothalamic amenorrhoea (20%) Prolactinoma (10%) Hyper- or hypothyroidism (5%) Non-functioning adenoma If shorter history, exclude pregnancy

Investigation of anovulation FSH, LH Prolactin (if amenorrhoea) Serum oestradiol TFTs Pelvic ultrasound Endometrial thickness Polycystic ovaries

AR aged 27 years 1 year history of secondary amenorrhoea - hoping to conceive No history of weight change Previous history of OCP use (but periods resumed after stopping) Examination unremarkable; BMI 23

Investigations: FSH 2.8 iu/l (3-11) LH 1.2 iu/l (3-11) Prolactin 3,500 mu/l (50-500)

Progress: Repeat prolactin 3,700 mu/l TSH 2.6 mu/l (0.5-5.0) MRI - microadenoma Management: dopamine agonists Started on bromocriptine 2.5 mg bd Suppression of prolactin to normal within 2 weeks Menses returned within 6 weeks Pregnant after 3 months of treatment

Polycystic ovarian syndrome Clinical Diagnosis: Clinical or biochemical hyperandrogenaemia Anovulation Rotterdam Polycystic ovaries Blood tests: E2: exclude hypogonadism Testosterone TFT Prolactin OGTT if FHx or overweight

Polycystic ovary normal normal PCO PCO more follicles, more stroma

Arrested antral follicle development in PCOS Normal LH > FSH PCOS Oestradiol > 100

What is your patient s treatment priority? PCOS: Mainly androgenic symptoms PCOS: Main problem is periods PCOS: Main problem is infertility

PCOS: Mainly androgenic symptoms Weight loss Cosmetic treatment All types of OCP suppress endogenous androgens Migraines caused by E2 Low mood caused by P Gastric symptoms caused by P 2 nd line. Spironolactone Anti-androgen Metformin will not help

PCOS: Main problem is periods Weight loss + exercise is highly effective if overweight OCP Wants regular bleeds: Cyclical E2 + P Does not want bleed: Continuous E2 + P OCP Metformin has slight effect only Ideal for glucose intolerance / DM

PCOS: Main problem is infertility Weight loss + exercise is highly effective (but difficult) Bariatric surgery if required Reassure Average 1.8 children per patient (normal = 2.2 in UK) Ovulation induction (clomiphene or FSH) or IVF

Secondary amenorrhoea. 24y woman Also some acne. Menarche aged 12y, with regular periods till went on OCP aged 16y. Stopped OCP 2y ago, and no periods since then No medications or concurrent medical problems No galactorrhoea

24y women: secondary amenorrhoea Mild ongoing acne on face Waxes facial hair once per month, but no chest or back acne or excessive hair No recent weight loss / Hx eating disorders Exercise: 3h per week in gym

On examination Weight 54kg. BMI 21.6kg/m2 Evidence of mild facial acne No hirsutism

What is the differential diagnosis?

Differential: secondary amenorrhoea in a woman < 40 years old PCOS (60%) Functional hypothalamic amenorrhoea (20%) Prolactinoma (10%) Hyper- or hypothyroidism (5%) Non-functioning adenoma If shorter history, exclude pregnancy

What investigations would you do? LH 0.5iU/L FSH 3.6iU/L Oestradiol <70pmol/L Do the results suggest PCOS? Testosterone: 0.8nmol/L Prolactin 187. TSH 1.01. FT4 10.2 Ultrasound : multiple cysts in L. and R. ovaries. 2mm endometrial thickness.

Hypothalamic amenorrhoea (probably functional) LH 0.5iU/L FSH 3.6iU/L Oestradiol <70pmol/L Testosterone: 0.8nmol/L This patients has hypogonadism, which is incompatible with diagnosis of PCOS Prolactin 187. TSH 1.01. FT4 10.2 Ultrasound : lots of cysts in R. ovary. L. ovary normal. 2mm endometrial thickness.

Hypothalamic amenorrhoea (probably functional) Acquired loss of GnRH secretion caused by: Weight loss Exercise Psychological stress Often resolves spontaneously Rx: E2 replacement / reduce exercise / psychological Refer if psychiatric disease / needs ovulation induction

Functional HA PCOS BMI usually <23kg/m2 Acne / hirsutism can be seen Polycystic ovarian appearances: possible E2 <100 pmol/l LH < 5iU/L FSH > LH BMI can be normal or high Acne / hirsutism can be seen Polycystic ovarian appearances: possible. E2 higher LH > 5iU/L LH > FSH

Case 2: Secondary amenorrhoea 28y woman BMI 24.5kg/m2 Menarche aged 13y, periods like clock-work every 30d 15/12 ago, periods less regular and frequent. Amenorrhoea for last 6/12

Blood tests TEST MARCH 17 Serum LH (iu/l) 12 Serum FSH (iu/l) 19 Serum E2 (pmol/l) 108

Blood tests TEST MARCH 17 JUNE 17 Serum LH (iu/l) 12 24 Serum FSH (iu/l) 19 42 Serum E2 (pmol/l) 108 <70

Blood tests TEST MARCH 17 JUNE 17 DEC 17 Serum LH (iu/l) 12 24 22 Serum FSH (iu/l) 19 42 39 Serum E2 (pmol/l) 108 <70 <70 What is the diagnosis?

Premature ovarian insufficiency Age < 40 years Amenorrhoea > 4 months FSH > 25iU/L on two occasions POI affects 10% of women < 40 years POI affects 1% of women < 30 years POI affects 0.1% of women < 20 years UK National Institute of Clinical Excellent (NICE) Guidelines 2015

Premature ovarian insufficiency What is her chance of future pregnancy? 4.4% in retrospective French series (n=358) Occurred < 4y following diagnosis What are her treatment options? IVF highly inadvisable unless periods restart Egg donation increasingly popular Bidet et al. JCEM 2011

FSH high Measure FSH FSH normal/low Management of women with anovulation POI Measure oestradiol HRT egg donation E2 normal PCOS E2 low hypothalamic/pituitary 1 st line: OCP Weight loss prolactin high Measure prolactin prolactin normal dopamine agonists FHA diet, psychotherapy GnRH, FSH/LH

Please contact us Dr. Channa Jayasena Ms. Lisa Webber Prof. Stephen Franks Channa.Jayasena@nhs.net